Home
News

News about CCII and Cancer Immunotherapy
Find out what is happening at CCII and in the field of cancer immunotherapy. Here we share the latest news about research at CCII and the CCII research community and about trends in immunology and cancer research.

Featured News

Spermidine to the Rescue?

Spermidine, a polyamine compound found in ribosomes and living tissues and originally isolated from semen, is an increasingly popular anti-aging supplement. Muna Al-Habsi and her colleagues demonstrate in a new paper published in Science that spermidine can enhance cancer immunotherapy blocking the PD-1 pathway by reversing aging effects in killer T-cells.

Apr 11, 2025
Bristol Myers Squibb Japan visited CCII

BMS–CCII Partnership Maintained and Strengthened.

More
Mar 14, 2025
The Multipurpose Hall is now available for use!

We invite you to use our wonderful hall with 176 seats for your events.

More
Feb 6, 2025
CCII Introduction Video Now Live!

We invite you to watch and explore the story behind CCII!

More
Jan 21, 2025
Highlights of the CCII Opening Ceremony and 1st International Symposium

Newly published highlights of the Opening Ceremony and 1st International Symposium

More
Nov 29, 2024
[CLOSED] Call for Applications for CCII’s 2025 Doctoral Program Scholarships

The Call for Applications for CCII's 2025 Doctoral Program Scholarships is closed. Application deadline was January 31st, 2025.

More

News about CCII and Cancer Immunotherapy Find out what is happening at CCII and in the field of cancer immunotherapy. Here we share the latest news about research at CCII and the CCII research community and about trends in immunology and cancer research.

Featured News

Spermidine to the Rescue?

All News

News about CCII and Cancer Immunotherapy
Find out what is happening at CCII and in the field of cancer immunotherapy. Here we share the latest news about research at CCII and the CCII research community and about trends in immunology and cancer research.